Insider filing · MNPR
Chandler Robinson
Chief Executive Officer
profile →
Monopar Therapeutics Inc.
MNPR · Healthcare · 11 filings in 24 months
ticker →
Chandler Robinson sold $672K of Monopar Therapeutics (MNPR)
Executed Jul 14 2025, disclosed Jul 16 2025, 2 days later.
Value, as filed
$672K
16,800 sh × $40.00
Executed
Jul 14 2025
the trade date, as filed
Disclosed
Jul 16 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
CRChandler Robinson (Chief Executive Officer) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Monopar Therapeutics Inc. (MNPR). The largest single filing was $672K of MNPR (16,800 sh × $40.00, as filed), executed Jul 14 2025.
The name
MNPRHealthcare · Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in th…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→